Evidence map›Paper›PMID 26177352›Full record

Trial reportPloS one2015

Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study.

Karen Smith-McCune, Joseph C Chen, Ruth M Greenblatt, Uma Shanmugasundaram, Barbara L Shacklett, Joan F Hilton, Brittni Johnson, Juan C Irwin, Linda C Giudice

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. [PSB0739 inhibits formation of semen-derived amyloid fibril].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Karen Smith-McCuneDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Joseph C ChenDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Ruth M GreenblattDepartments of Clinical Pharmacy and Internal Medicine, University of California San Francisco, San Francisco, California, United States of America; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
Uma ShanmugasundaramDepartment of Medical Microbiology and Immunology, School of Medicine, University of California Davis, Davis, California, United States of America.
Barbara L ShacklettDepartment of Medical Microbiology and Immunology, School of Medicine, University of California Davis, Davis, California, United States of America.
Joan F HiltonDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.
Brittni JohnsonDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Juan C IrwinDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
Linda C GiudiceDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USUniversity of California, Davis · US

Funding

Trophoblast Differentiation in In Vivo and In Vitro Fertilized EmbryosU54HD055764 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TRAN, NAM D · 2007 to 2013
$11.5M
Viral and Host Factors Promoting Male-to-Female Transmission of HIVP01AI083050 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI SHACKLETT, BARBARA L. · 2009 to 2013
$10.1M
Project 3: Identifying plasma biomarkers predicting time to HIV rebound after treatment interruptionP01AI131374 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI ROAN, NADIA R · 2017 to 2021
$8.5M
Factors That Affect Endometrial Immunity: Implications for HIV InfectionF32HD074423 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, JOSEPH C. · 2012 to 2015
$158k
NIAID NIH HHS P01 AI083050NIAID NIH HHS P01 AI131374NICHD NIH HHS 1F32HD074423-02NICHD NIH HHS F32 HD074423NICHD NIH HHS U54 HD055764NICHD NIH HHS U54HD055764
6 · The paper itself

Abstract

Intravaginal anti-HIV microbicides could provide women with a self-controlled means for HIV prevention, but results from clinical trials have been largely disappointing. We postulated that unrecognized effects of intravaginal gels on the upper female reproductive tract might contribute to the lower-than-expected efficacy of HIV microbicides. Our objective was to study the effects of intravaginal gels on the immune microenvironment of the cervix and uterus. In this randomized crossover study, 27 healthy female volunteers used a nightly application of intravaginal nonoxynol-9 (N9) gel as a "failed" microbicide or the universal placebo gel (UPG) as a "safe" gel (intervention cycles), or nothing (control cycle) from the end of menses to the mid-luteal phase. At a specific time-point following ovulation, all participants underwent sample collection for measurements of T-cell phenotypes, gene expression, and cytokine/chemokine protein concentrations from 3 anatomic sites above the vagina: the cervical transformation zone, the endocervix and the endometrium. We used hierarchical statistical models to estimate mean (95% CI) intervention effects, for N9 and UPG relative to control. Exposure to N9 gel and UPG generated a common "harm signal" that included transcriptional up-regulation of inflammatory genes chemokine (C-C motif) ligand 20 (macrophage inflammatory factor-3alpha) and interleukin 8 in the cervix, decreased protein concentrations of secretory leukocyte protease inhibitor, and transcriptional up-regulation of inflammatory mediators glycodelin-A and osteopontin in the endometrium. These results need to be replicated with a larger sample, but underscore the need to consider the effects of microbicide agents and gel excipients on the upper female reproductive tract in studies of vaginal microbicides.

Indexed as

Administration, IntravaginalAdultAnti-HIV AgentsCellular MicroenvironmentCervix UteriCross-Over StudiesFemaleGelsHumansInflammationNonoxynolPhenotypePlacebosT-LymphocytesTranscriptomeUterusAnti-HIV AgentsGelsNonoxynolPlacebos

Identifiers

PMID26177352
PMCPMC4503751
OpenAlexW1523225656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.